GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP

24 min · 7. huhti 2026
jakson GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP kansikuva

Kuvaus

Join host Julia Cartwright as she explores tirzepatide's groundbreaking FDA approval for obstructive sleep apnea in adults with obesity. We discuss clinical trials showing remarkable AHI reductions, why CPAP adherence fails millions, the drug's multi-pathway mechanisms, and what this pharmaceutical option means for personalized sleep medicine treatment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity GLP-1 Drugs and Sleep Apnea — A Breakthrough?-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

5 jaksot

jakson GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright kansikuva

GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright

Join Julia Cartwright as she explores the groundbreaking approval of GLP-1 drugs for sleep apnea treatment, a potential game-changer for thirty million Americans frustrated with traditional CPAP therapy. Discover the real science, patient outcomes, and what this breakthrough means for anyone seeking alternatives that actually work. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 202632 s
jakson GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP kansikuva

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP

Join host Julia Cartwright as she explores tirzepatide's groundbreaking FDA approval for obstructive sleep apnea in adults with obesity. We discuss clinical trials showing remarkable AHI reductions, why CPAP adherence fails millions, the drug's multi-pathway mechanisms, and what this pharmaceutical option means for personalized sleep medicine treatment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 202624 min
jakson GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story kansikuva

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story

Host Julia Cartwright explores groundbreaking research on GLP-1 drugs and sleep apnea, revealing how medications like tirzepatide work beyond weight loss through brain receptors, anti-inflammatory effects, and metabolic improvements. Drawing on SURMOUNT-OSA trials and emerging science, she explains why these multi-pathway treatments are revolutionizing our understanding of obstructive sleep apnea as a whole-body condition. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 202624 min
jakson GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story kansikuva

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story

Host Julia Cartwright explores groundbreaking research on GLP-1 drugs and sleep apnea, revealing how medications like tirzepatide work beyond weight loss through brain receptors, anti-inflammatory effects, and metabolic improvements. Drawing on SURMOUNT-OSA trials and emerging science, she explains why these multi-pathway treatments are revolutionizing our understanding of obstructive sleep apnea as a whole-body condition. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 202624 min
jakson GLP-1 Drugs and Sleep Apnea — A Breakthrough? - The Trial That Changed Everything kansikuva

GLP-1 Drugs and Sleep Apnea — A Breakthrough? - The Trial That Changed Everything

Join Julia Cartwright as she explores the groundbreaking FDA approval of tirzepatide (Zepbound) for obstructive sleep apnea—the first medication ever approved for this condition. We dive into the SURMOUNT-OSA trials, examining how this weight-loss drug reduced breathing interruptions and eliminated symptoms in 50% of participants, offering new hope beyond CPAP. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 202623 min